Lundeos, capsule molle
7680677960017
CH-67796
capsule molle
Associated product:
LUNDEOS caps moll 20000 UI 4 pce
1 / 3
google
Article details
- Package size
- 4
- Selling units
- 4
- Measure
- Kapsel(n)
- Galenic form
- capsule molle
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
cholecalciferolum
|
20000.0 UI | Substance | Wirkstoff (Principe actif) |
|
cholecalciferolum
|
500.0 UG | Substance | WIIS |
|
triglycerida media
|
- | Substance | HNIDK |
|
int-rac-alpha-tocopherylis acetas
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
glycerolum
|
- | Substance | HNIDK |
|
sorbitolum liquidum partim deshydricum
|
- | Substance | HNIDK |
|
sorbitolum
|
- | Substance | HBESI |
|
aqua purificata
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2022
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 67796
- Drug name
- Lundeos, capsule molle
- Galenic form
- KAPWE
- ATC Code
- A11CC05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 17/02/2022
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.02.3.
- Domain
- Human medicine
Package details
- Description (FR)
- LUNDEOS caps moll 20000 UI 4 pce
- Description (DE)
- LUNDEOS Weichkaps 20000 IE 4 Stk
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No
Other package sizes (1)
LUNDEOS caps moll 20000 UI 2 x 4 pce
2 x 4 KAP
GTIN: 7680677960031